Quantcast

Latest Clinical research Stories

2014-06-18 23:16:45

On May 28, the FDA announced that the previous recall of certain lots of NaturaLyte Liquid Bicarbonate Concentrate 6.4 liters, by Fresenius Medical Care North America, is classified as Class I. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) June 18, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on...

2014-06-18 23:14:03

Cambridge Biomedical is excited to add video production services to its range of offerings. Targeted at streamlining the clinical trial sample collection process and reducing error rates. Boston, MA (PRWEB) June 18, 2014 Cambridge Biomedical is excited to add video production services to its range of offerings. This addition is targeted at streamlining the sample collection process for clinical trials and assisting in ensuring sample preparation consistency between collection sites....

2014-06-18 23:08:45

Bellwether Trials Expected to Begin in Either Mid-2015 or Early 2016 DALLAS (PRWEB) June 18, 2014 The national law firm of Baron and Budd reports that the U.S. District Court, District of Massachusetts held a Status Conference on May 9, 2014 in regard to federal multidistrict litigation (MDL) for GranuFlo lawsuits. The Court filed a Joint Status Report stating that, included in the matters discussed during the conference were potential dates for the MDL’s bellwether trials. According to...

2014-06-18 16:27:02

BETHESDA, Md., June 18, 2014 /PRNewswire-USNewswire/ -- The Parenteral Drug Association has confirmed the participation of 27 officials from the U.S. FDA, including CDER Director Janet Woodcock, MD, as speakers at the 2014 PDA/FDA Joint Regulatory Conference. Besides the Office for Drug Evaluation and Research (CDER), the FDA Centers for Biologics Evaluation and Research (CBER), Devices and Radiological Health (CDRH), and Veterinary Medicine (CVM), along with the Office of Regulatory...

2014-06-18 16:26:53

KANSAS CITY, Kan., June 18, 2014 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for cats, dogs and other companion animals, today announced that it is currently enrolling patients in two nationwide clinical trials to evaluate its monoclonal antibody for canine T-cell lymphoma, AT-005, which is conditionally licensed by the USDA to aid in the treatment of...

2014-06-18 12:38:03

LONDON, June 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Drug Discovery Outsourcing: World Market Forecast 2014-2024 & Future Prospects for Leading Companieshttp://www.reportbuyer.com/pharma_healthcare/drug_discovery/drug_discovery_outsourcing_world_market_forecast_2014_2024_future_prospects_leading_companies.html Report DetailsDrug discovery outsourcing - discover trends and segments with highest revenue potentialWhat does the future hold...

2014-06-18 12:36:30

LONDON, June 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Orphan Drugs for CNS Diseases: R&D and Market 2014-2024http://www.reportbuyer.com/pharma_healthcare/therapeutic/orphan_drugs_cns_diseases_rd_market_2014_2024.html Report DetailsUncommon nerve disorders - new study explains technological and commercial prospectsWhat's the future of medicines for rare central nervous system (CNS) disorders? Visiongain's new report gives you predictions...

2014-06-18 08:29:26

BUENA, N.J., June 18, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced it has submitted its third abbreviated new drug application (ANDA) in 2014 to the U.S. Food and Drug Administration (FDA), which brings the Company's total number of ANDA submissions to sixteen, with fourteen now pending at the FDA. http://photos.prnewswire.com/prnvar/20130827/MM70487LOGO Jason Grenfell-Gardner, President and...

2014-06-17 23:09:08

Wireless Solution Delivers Cost Savings and Real-time Access to Key Patient Data Philadelphia, PA (PRWEB) June 17, 2014 ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market its AM3® GSM devices in respiratory clinical trials. The AM3 GSM device provides a robust and reliable wireless option for clinical trial patients to...

2014-06-17 20:23:58

RESEARCH TRIANGLE PARK, N.C., June 17, 2014 /PRNewswire-USNewswire/ -- Contract research organizations aren't what they used to be. But they are where they used to be: in North Carolina. North Carolina reigns, after more than three decades of growth and change in the industry, as the CRO epicenter of the world. It's just one of the state's successes featured at next week's BIO International Convention in San Diego. The story really got rolling in February 1982 from a trailer parked...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related